Thomas Friel

Thomas Friel is an accomplished professional in the field of quality assurance and regulatory compliance within the pharmaceutical industry. Currently serving as Director of Enterprise Quality Auditing at Endo and Director of GMP/GDP Audits and Inspection Readiness at Bristol Myers Squibb since April 2023, Friel also holds the position of Senior Director of QA Compliance at Center for Breakthrough Medicines and Associate Director of Quality Assurance at Organon. Friel's extensive experience includes a previous role as Associate Director of Quality Assurance for GMP Compliance at Merck and as a Drug Specialist and Consumer Safety Officer at the FDA, where responsibilities included conducting complex inspections to ensure GMP compliance. Friel's educational background includes a Bachelor’s Degree in Biology from La Salle University, a Biomanufacturing Process Certificate from North Carolina State University, and a Master’s Degree in Quality Assurance/Regulatory Affairs from Temple University Graduate School.